PHARMACOLOGY OF PSYCHOTROPIC-DRUGS USEFUL IN DERMATOLOGICAL PRACTICE

被引：8

作者：

KOBLENZER, CS

机构：

[1] UNIV PENN,SCH MED,DEPT DERMATOL,PHILADELPHIA,PA 19104

[2] UNIV PENN,SCH MED,DEPT DERMATOL PSYCHIAT,PHILADELPHIA,PA 19104

来源：

INTERNATIONAL JOURNAL OF DERMATOLOGY | 1993年 / 32卷 / 03期

关键词：

D O I：

10.1111/j.1365-4362.1993.tb02786.x

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

[No abstract available]

引用

页码：162 / 168

页数：7

共 31 条

[1]

ALTESMAN RI, 1983, J CLIN PSYCHIAT, V44, P12

[2]

BARABAN JM, 1989, COMPREHENSIVE TXB PS, V5

[3]

BERNSTEIN JG, 1988, HDB DRUG THERAPY PSY

[4]

CAVENAR JO, 1974, PSYCHOSOMATICS, V17, P128

[5] BUTYROPHENONE INFLUENCES ON OPIATE RECEPTOR [J].

CREESE, I ;

FEINBERG, AP ;

SNYDER, SH .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1976, 36 (01) :231-235

[6]

DAVIS JM, 1989, COMPREHENSIVE TXB PS, V5, P1623

[7] TREATING DEPRESSION AND ANXIETY IN PRIMARY CARE - CLOSING THE GAP BETWEEN KNOWLEDGE AND PRACTICE [J].

EISENBERG, L .

NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (16) :1080-1083

[8]

FRANCES A, 1989, HOSP COMMUNITY PSYCH, V40, P1113

[9] FOLLOW-UP-STUDY ON CHEMOTHERAPY OF NEURODERMATITIS WITH A MONO-AMINE OXIDASE INHIBITOR [J].

FRIEDMAN, S ;

KANTOR, I ;

SOBEL, S ;

MILLER, R .

JOURNAL OF NERVOUS AND MENTAL DISEASE, 1978, 166 (05) :349-357

[10]

FULOP G, 1987, AM J PSYCHIAT, V144, P673

← 1 2 3 4 →